Safety of Perfluorobutane (Sonazoid) in Characterizing Focal Liver Lesions

BACKGROUND: The purpose of this study was to report the safety of perfluorobutane (Sonazoid) as a vascular-phase imaging agent in characterizing focal liver lesions (FLLs). MATERIALS AND METHODS: From May 2014 to April 2015, a total of 54 individuals who received Sonazoid contrast-enhanced ultrasoun...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Yi-Hong, Liang, Ja-Der, Wang, Shen-Yung, Hsu, Shih-Jer, Hu, Jui-Ting, Yang, Sien-Sing, Wang, Hsin-Kai, Lee, Tien-Ying, Tiu, Chui-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607878/
https://www.ncbi.nlm.nih.gov/pubmed/31316217
http://dx.doi.org/10.4103/JMU.JMU_44_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607878/
https://www.ncbi.nlm.nih.gov/pubmed/31316217
http://dx.doi.org/10.4103/JMU.JMU_44_19

Ejemplares similares